Skip to content
  • Careers
  • Contact
Pyxis Oncology Logo
  • About
    • Overview
    • Leadership
    • Partners
  • Our Approach
    • ADC Landscape
    • I/O Landscape
  • Portfolio
    • A Novel Pipeline
    • ADCs
    • Our Target Catalog
  • Investors
    • News releases
    • Events & presentations
    • Corporate governance
      • Governance Overview
      • Board of Directors
      • Management Team
      • Committee composition
    • Financial Information
      • SEC filings
    • Stock Information
      • Stock quote & chart
    • SHAREHOLDER SERVICES
      • Investor FAQs
      • Email alerts
      • RSS feeds
  • Media Coverage
Pyxis Oncology Logo
  • About
    • Overview
    • Leadership
    • Partners
  • Our Approach
    • ADC Landscape
    • I/O Landscape
  • Portfolio
    • A Novel Pipeline
    • ADCs
    • Our Target Catalog
  • Investors
    • News releases
    • Events & presentations
    • Corporate governance
      • Governance Overview
      • Board of Directors
      • Management Team
      • Committee composition
    • Financial Information
      • SEC filings
    • Stock Information
      • Stock quote & chart
    • SHAREHOLDER SERVICES
      • Investor FAQs
      • Email alerts
      • RSS feeds
  • Media Coverage
  • Careers
  • Contact

Media Coverage

March 18, 2021

Pfizer ships out 2 cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO

March 18, 2021

Pfizer Grants Pyxis Oncology Licenses to Develop Two Antibody-Drug Conjugate Candidates

March 18, 2021

Other news to note for March 18, 2021

« Previous 1 2 3 4

35 Cambridgepark Drive
Suite 100-R
Cambridge, MA 02140
(617) 453-3596 | info@pyxisoncology.com

Pyxis Oncology
Twitter Linkedin-in
  • Copyright © 2022 Pyxis Oncology
  • Privacy Policy
  • Accessibility